Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Vaccines in the Aging Population

The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population’ is at an increased risk.

From Pfizer, Inc. 13 Nov 2017

Healthcare organizations urge Congress to take immediate action on drug shortages

ASHP, together with five other healthcare organizations, today sent a letter to Reps. Morgan Griffith and Diana DeGette - the Vice Chairman and Ranking Member, respectively, of the House Energy and Commerce Subcommittee on Oversight and Investigations - asking Congress to take immediate action to address the public health crisis caused by persistent shortages of critical medications.

10 Nov 2017

Study identifies promising treatment to reduce brain injury in babies

Research-clinicians at Children's National Health System led the first study to identify a promising treatment to reduce or prevent brain injury in newborns who have suffered hypoxia-ischemia, a serious complication in which restricted blood flow deprives the brain of oxygen.

10 Nov 2017

Russian scientists uncover previously unknown effect of leukemia drug

Researchers from RUDN University and Institute of Biomedical Chemistry of the Russian Academy of Sciences have identified an alternative mechanism for the effective antitumor drug -- an enzyme called L-asparaginase.

10 Nov 2017

Researchers find distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness

Researchers at Georgetown University Medical Center have found distinct molecular signatures in two brain disorders long thought to be psychological in origin -- chronic fatigue syndrome (CFS) and Gulf War Illness (GWI).

10 Nov 2017

Laws to equalize cancer patients’ out-of-pocket costs provide uneven protection

Laws passed by many states that require health plans to charge the same cost-sharing amounts for cancer patients receiving chemotherapy — regardless of whether they get the medication intravenously or take a pill or liquid by mouth — are providing uneven pocketbook protection, according to a new study.

10 Nov 2017

Drinking alcohol linked to cancer says American Society of Clinical Oncology (ASCO)

Cancer specialists and researchers from the American Society of Clinical Oncology (ASCO), released a statement this week, that drinking alcohol is linked with cancer. Their statement was published titled, “Alcohol and Cancer: A Statement of the American Society of Clinical Oncology”, in the Journal of Clinical Oncology.

9 Nov 2017

Parity laws may not fully address affordability for patients needing cancer drugs

State laws designed to ensure that the pill form of cancer drugs is not more costly than treatments given through an infusion in a clinic or hospital have had a mixed impact on patients' pocketbooks, according to University of North Carolina Lineberger Comprehensive Cancer Center researchers.

9 Nov 2017

Alcohol intake is linked to cancer, something most Americans are unaware of, warns ASCO

Alcohol consumption is a definite risk factor for several cancers, irrespective of whether intake is light, moderate or heavy, according to a statement released by the American Society of Clinical Oncology (ASCO).

9 Nov 2017

Elevated levels of chronic stress hormones may promote EGFR inhibitor resistance in NSCLC patients

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center.

9 Nov 2017

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

9 Nov 2017

3D cultured spheroids could drive precision treatment for ovarian cancer

Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.

9 Nov 2017

Scientists uncover mechanism that prevents tumor growth in melanoma

Natural Killer (NK) cells, lymphocytes of the innate immune system with strong cytotoxic activity, play a major role in the immune response against tumors.

8 Nov 2017

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

DGIST's research team led by Dr. Yun-Il Lee in Well-Aging Research Center has identified a new mechanism of inhibition of dopaminergic neuronal apoptosis and suggested the possibility of preventing and treating Parkinson's disease.

8 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Study reveals link between circulating tumor cells and relapse in late-stage melanoma patients

A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites.

7 Nov 2017

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Researchers identify new neuroprotective factor that holds potential to help people with glaucoma

A research team led by scientists at the Krembil Research Institute in Toronto has identified a new neuroprotective factor that has the potential to help people suffering from the common blinding disease glaucoma.

7 Nov 2017

FDA grants clearance to new blood cell count test that allows faster availability of results

The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians' offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.

6 Nov 2017

Oncology News and Research

Further Reading

Vaccines in the Aging Population

Healthcare organizations urge Congress to take immediate action on drug shortages

Study identifies promising treatment to reduce brain injury in babies

Russian scientists uncover previously unknown effect of leukemia drug

Researchers find distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness

Laws to equalize cancer patients’ out-of-pocket costs provide uneven protection

Drinking alcohol linked to cancer says American Society of Clinical Oncology (ASCO)

Parity laws may not fully address affordability for patients needing cancer drugs

Alcohol intake is linked to cancer, something most Americans are unaware of, warns ASCO

Elevated levels of chronic stress hormones may promote EGFR inhibitor resistance in NSCLC patients

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

3D cultured spheroids could drive precision treatment for ovarian cancer

Scientists uncover mechanism that prevents tumor growth in melanoma

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Study reveals link between circulating tumor cells and relapse in late-stage melanoma patients

FDA approves first targeted cancer treatment based on basket study

FDA grants approval to first treatment for rare blood cancer

Researchers identify new neuroprotective factor that holds potential to help people with glaucoma

FDA grants clearance to new blood cell count test that allows faster availability of results

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News